Divyam Pharmaceuticals

Combination Antiretroviral Therapy: Used in the treatment of HIV-1 infection and for HIV pre-exposure prophylaxis (PrEP) in high-risk individuals.

Once-Daily Oral Dose: Administered as a single tablet taken once daily, with or without food. Consistent daily intake is essential for effectiveness.

Dual Mechanism of Action: Both Tenofovir and Emtricitabine inhibit reverse transcriptase, an enzyme HIV uses to replicate, thus reducing the viral load.

Monitoring and Side Effects: Generally well-tolerated, though may cause nausea, headache, and in rare cases, reduced kidney function or decreased bone mineral density; regular monitoring is advised.

Used in HIV and Hepatitis B Treatment: Commonly prescribed for managing chronic Hepatitis B infection and as part of combination antiretroviral therapy for HIV-1.

Prodrug with Targeted Delivery: Tenofovir Alafenamide (TAF) is a prodrug that delivers the active drug more efficiently to lymphoid cells, allowing for lower dosing with reduced systemic exposure.

Better Safety Profile: Compared to earlier tenofovir formulations (like TDF), TAF causes less impact on kidneys and bone mineral density, making it safer for long-term use.

Once-Daily Oral Dosing: Administered as a single tablet once daily, with or without food, depending on the regimen and indication.

Antiviral for CMV Infections
Used primarily for the treatment of cytomegalovirus (CMV) retinitis in AIDS patients and for the prevention of CMV disease in organ transplant recipients.

Oral Prodrug of Ganciclovir
Valganciclovir is converted in the body to ganciclovir, which inhibits viral DNA synthesis and controls CMV replication effectively.

Flexible Dosing
Usually prescribed as 900 mg once or twice daily depending on the treatment or prevention regimen. Dose adjustments are required for patients with renal impairment.

Common Side Effects
May include anemia, neutropenia, diarrhea, nausea, and headache. Regular blood count monitoring is recommended during treatment.

Antifungal Medication
Caspofungin is used to treat serious fungal infections such as invasive candidiasis, esophageal candidiasis, and invasive aspergillosis—especially in patients who are intolerant or unresponsive to other antifungals.

Echinocandin Class
It belongs to the echinocandin class, which works by inhibiting the synthesis of β-(1,3)-D-glucan, an essential component of fungal cell walls, leading to fungal cell death.

Intravenous Administration
Given via IV infusion, typically starting with a 70 mg loading dose followed by daily maintenance doses (commonly 50 mg), adjusted based on the patient's condition and response.

Well-Tolerated Profile
Common side effects may include fever, chills, rash, elevated liver enzymes, and mild infusion-related reactions. It is generally considered safe with a low risk of drug interactions.